Based on solid scientific theory, Lumentin® is expected to provide completely new opportunities for high quality, image-based abdominal diagnostics with CT technology. This means that MRI scans of the small intestine might well be replaced without sacrificing diagnostic safety, at the same time reducing the waiting time for patients in need for a MRI-scan.

Currently, four clinical trials – internal and multi centre studies – are being planned to verify the results achieved on healthy volunteers and to show expected accuracy in early detection and diagnosis of bowel diseases. The first of the four studies started in November 2017.

In parallel, sensory properties, production methods and user-friendliness in the clinic are under further development.